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 Folate deficiency has been linked to multiple health problems including neural 
tube defects and cancer, especially colorectal cancer.  Folate is an essential dietary 
vitamin that is required for DNA synthesis and cellular methylation reactions.  The 
mechanistic links between these associations is not completely understood.  Folate 
deficiency has been shown to affect genes associated with the Wnt pathway, including  
β-catenin.  E-cadherin is an important regulator of Wnt signaling through controlling the 
level of free β-catenin.  It has also been shown that E-cadherin is affected by folate 
deficiency.  The purpose of this study was to determine if folate deficiency altered the 
levels of E-cadherin protein and RNA, β-catenin protein, and E-cadherin and β-catenin 
cellular localization in two colon epithelial cell lines.  Caco-2 and FHC cells were grown 
for 15 and 30 days in folate sufficient and deficient medium.  Cellular growth rates for 
both cell lines were reduced in folate deficient cells, although the cells continued to grow.  
Cell cycle phase distribution showed increases in S phase and G2/M phase in Caco-2 
cells, whereas there was no change in FHC cells.  E-cadherin and β-catenin protein levels 
decreased slightly in folate deficient Caco-2 cells at days 15 and 30.  This was associated 
with a decrease in E-cadherin transcripts at day 30.  FHC cells showed similar results at 
day 15, but a small increase in E-cadherin protein at day 30 and no change in β-catenin.  
Immunofluorescent staining of Caco-2 cells showed diffuse cytoplasmic staining of E-
cadherin and β-catenin in folate sufficient cells for both Caco-2 and FHC cells.  Folate 
deficient Caco-2 cells showed no change in E-cadherin, but an increase in membrane 
associated β-catenin.  Folate deficient FHC cells showed an increase in nuclear 
localization of both E-cadherin and β-catenin.  The AKT pathway was also analyzed in 
Caco-2 cells to determine if alterations in this growth regulatory pathway was associated 
with folate deficiency.  In Caco-2 cells, an increase in activated AKT was detected at day 
30 in folate deficient cells, and other proteins in the AKT pathway (PDK1, PTEN, and  
c-Raf) showed slight decreases whereas a small increase was detected for GSK-3β.  
Finally, we confirmed published findings that Caco-2 cells were adapting to folate 
deficiency by upregulating the folate transporters:  folate receptor 1 (FolR-1) and reduced 
folate carrier (RFC).  In general, those results suggest that alterations in E-cadherin and  
β-catenin occur in folate deficient colon epithelial cells, although the cells can adapt and 
continue to proliferate. 
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CHAPTER I 
 
INTRODUCTION 
 
 
 
Statement of Problem 
 The purpose of this study is to determine if folate deficiency causes any 
alterations in the protein levels and localization of E-cadherin and β-catenin in two colon 
epithelial cell lines. 
 There is strong epidemiological data supporting a relationship between a diet rich 
in fruits and vegetables and decreased risk of cancer.  However, the molecular basis for 
this relationship is still not well defined.  Folate is an essential vitamin derived from the 
diet.  The metabolites of the folate pathway are required for synthesis of nucleotides for 
DNA synthesis and methyl donors for methylation reactions.  Folate deficiency has been 
associated with increased risk of various cancers, in particular, colorectal cancer. 
 The Wnt signaling pathway is highly conserved and critically important in 
cellular growth, proliferation, and development.  As such, the Wnt pathway has been 
studied extensively to elucidate its role in various forms of cancer.  Mutations in the Wnt 
signaling pathway genes, such as APC, are commonly found in colorectal cancer.    
 E-cadherin is a protein that is important in cell-cell adhesion and regulates cell 
growth.  This protein is involved in the Wnt signaling pathway by its interaction with β-
catenin, an important transcription factor and downstream effector molecule of the 
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canonical Wnt pathway.  The E-cadherin protein has also been implicated in cancer, as a 
reduction in this protein is common in transformed cells. 
 The relationship between folate deficiency, Wnt signaling, and E-cadherin is the 
focus of this project.  E-cadherin and β-catenin protein levels and cellular localization 
will be compared in folate sufficient and deficient normal and transformed colon 
epithelial cells.  The hypotheses are that 1) the level of E-cadherin protein is reduced in 
folate deficient cells as compared to folate sufficient cells and 2) the cellular localization 
of E-cadherin and β-catenin will be altered in folate deficient cells in comparison to folate 
sufficient cells.   
 In addition, the AKT signaling pathway will be analyzed in cells grown under 
folate sufficient and deficient conditions.  The AKT pathway is a major growth 
regulatory pathway in the cell and is likely affected by folate deficiency.  Moreover, AKT 
has been shown to be involved in the levels of β-catenin and its cellular localization. 
Folate Pathway and Metabolism 
 Folate is an essential dietary B-vitamin that cannot be synthesized.  It is obtained 
through a diet that includes leafy green vegetables, broccoli, citrus fruits, dry cereals, and 
organ meats.  It can also be obtained through dietary supplements that contain folic acid.  
After folate is ingested it is absorbed by the enterocytes of the small intestines and enters 
the blood.  Folate travels through the blood plasma bound to albumin, a high affinity 
folate binding protein, and erythrocytes.  The serum level of folate is regulated by the 
liver (Lucock, 2000). 
 3 
Folate is transported from the plasma into cells through a variety of mechanisms.  
A low affinity reduced folate carrier (RFC) functions as a carrier that directly moves 
folate into the cell. There are also high affinity folate receptors (FR), which move folate 
into the cells via endocytosis (Kim, 2007).  Once plasma folate has entered the cell it is 
converted to 7,8-dihydrofolate and then converted to tetrahydrofolate (THF) by the 
enzyme dihydrofolate reductase (DHFR).  The THF is converted to 5,10-methyleneTHF, 
which through the enzymatic activity of methylenetetrahydrofolate reductase (MTHFR), 
is converted to 5-methylTHF.  This is the main form of folate found in the plasma, which 
provides the methyl group for de novo methionine synthesis.  5,10-methyleneTHF is also 
converted to 10-formylTHF, which is used for purine synthesis for DNA.  It is also used 
for conversion of deoxyuridylate to thymidylate via thymidylate synthetase (Figure 1B).  
This is the pathway used for generating the nucleotide precursors for DNA synthesis. 
 The folate pathway is also responsible for producing methyl donors for de novo 
DNA methylation reactions (Figure 1A).  5,10-methyleneTHF is converted to 5-
methylTHF and this provides the methyl group necessary to convert homocysteine to 
methionine.  The newly produced methionine is converted to S-adenosylmethionine 
(SAM).  This is the major methyl donor for methylation reactions such as DNA 
methylation.   SAM is converted to S-adenosylhomocysteine (SAH) after the methyl 
group is removed from SAM for various methylation reactions.  SAH is converted back 
to homocysteine (Lucock, 2000; J Ma et al., 1997).  Importantly, SAH is a strong 
inhibitor of SAM-dependent methyltransferases and is a strong predictor of 
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hypomethylation.  Studies have shown the levels of SAH increase in folate deficient cells 
(James et al., 2002; Jhaveri et al., 2001). 
 
 
Figure 1:  Folate Pathway.  A) Methylation of Homocysteine to Methionine. 
B) Biosynthesis of Purines and Pyrimidines. 
  
Abbreviations:  DHFR, Dihydrofolate Reductase; MTHFR, Methylenetetrahydrofolate Reductase; SAM, 
S-adenosylmethionine, SAH, S-adenosylhomocysteine; TS, Thymidylate Synthetase. 
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Folate Deficiency and Cancer 
 Folate has been shown to be a risk factor in some types of cancer.  In particular, 
increased risk of colorectal cancer has been strongly correlated with folate deficiency.  
The basis for this increased risk has not been definitively determined, but it is a 
reasonable assumption that it results from the multiple cellular consequences of folate 
deficiency.  These would include decreased cell proliferation, increased DNA damage, 
impaired DNA repair, and altered DNA methylation patterns (Ma et al., 2005).   
Folate deficiency has been found to induce chromosome breaks by causing 
deoxynucleotide pool imbalances.  In folate deficient cells, the amount of 5,10-
methyleneTHF is reduced, which is required to convert deoxyuridylate to thymidylate.  
This can cause an accumulation of deoxyuridylate, which becomes incorporated into new 
strands of DNA.  The removal of these abnormal bases increases the possibilities of DNA 
strand breaks (Kim, 2007).  In the colonic mucosa of rats it was found that exons 5-8 of  
p53, a tumor suppressor gene, were very susceptible to strand breaks due to folate 
deficiency (Novakovic et al., 2005).  This loss of p53 function is common in most 
cancers. 
Mutations in the gene for MTHFR, an enzyme in the folate pathway (see Figure 
1), has also been shown to increase the risk of colorectal cancer through reduced plasma 
folate and increased plasma homocysteine (Ma et al., 1997).  Supporting the idea that 
folate deficiency increases cancer risk, mutations have also been identified in the folate 
receptors RFC1 and Folbp1 that affected the folate levels in colonocytes.  The reduced 
activity of Folbp1 due to mutation caused a decreased amount of folate to be reabsorbed 
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by the kidneys, leading to reduced folate levels in the plasma and tissue (Ma et al., 2005).  
These findings suggest that folate deficiency caused by reduced folate transporters 
increases the risk of colorectal cancer. 
The Wnt Signaling Pathway 
 The Wnt signaling pathway was originally characterized from research on 
colorectal cancer (Jin et al., 2008).  Since then, much more has been discovered about 
this important signaling pathway.  There are 16 Wnt ligands that have been characterized 
in vertebrates.  These ligands are secreted and bind to various cell surface receptors to 
promote cell growth, proliferation, and differentiation.  The Wnt proteins are highly 
conserved, which is indicative of this pathway’s importance. 
 The canonical Wnt pathway is stimulated when a secreted Wnt ligand, such as 
Wnt-3a, associates with Frizzled, a seven transmembrane cell surface receptor (Figure 2).  
These ligands will also associate with low density lipoprotein receptor-related protein 
(LRP).  Receptor stimulation causes the promotion of a Wnt receptor complex that 
recruits the proteins Disheveled and Axin.  This complex allows for the stabilization of β-
catenin, leading to a rise in cytoplasmic levels of β-catenin.  The β-catenin protein is the 
effector molecule of the Wnt pathway, and is an important transcription factor.  With a 
rise in cytoplasmic levels, β-catenin localizes to the nucleus and complexes with the co-
activators T-cell factor (TCF) and lymphoid enhancer factor (LEF).  This complex then 
initiates gene transcription through binding to various promoter regions of specific genes, 
including cyclin D1 and Myc.     
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 When no Wnt ligand associates with its receptors, β-catenin is rapidly degraded.  
This is controlled by a complex of adenomatous polyposis coli (APC), axin, and 
glycogen synthase kinase (GSK)-3β that associate with cytoplasmic β-catenin.  This 
complex causes phosphorylation of β-catenin and targets it for ubiquitinization.  The 
targeted β-catenin is then degraded by a proteosome system.  This reduces the amount of 
available β-catenin that can move to the nucleus, and causes a reduction in gene 
transcription (Polakis, 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Canonical Wnt Signaling Pathway.  See text for explanation. 
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The Wnt Pathway and Cancer 
 Many studies have shown that aberrant regulation of the Wnt pathway leads to 
various forms of cancer.  It has been shown that this aberrant Wnt signaling is an early 
event in 90% of human colorectal cancers (Fodd et al., 2001).  There are multiple 
mutations in the Wnt pathway that can cause cancer.  Mutations in the APC gene play a 
major role in colorectal cancer.  It is widely agreed upon that mutations in APC and 
reduced expression alter Wnt signaling, which is the cause of more than 85% of sporadic 
colorectal cancers (Liu et al., 2007).  Inherited colorectal cancer patients normally have 
germ line mutations of the APC gene (Jin et al., 2008).  These mutations reduce the levels 
of APC, causing an increase in the level of available β-catenin that can move to the 
nucleus and initiate transcription.  Normal cells contain very low levels of β-catenin in 
the nucleus unless they are at certain stages of development or are tumor cells (Ki et al., 
2008).  The majority of β-catenin activity in colorectal epithelium is found in the bottom 
of colonic crypts where the epithelial stem cells are located.  The colonic villi tips 
normally have low levels of β-catenin and high levels of APC (Voutsadakis, 2008).  APC 
mutations lead to increased β-catenin levels in these cells, which increase cellular growth 
and formation of lesions associated with colorectal cancer.   
 There are other mutations in the Wnt pathway that can lead to an increased risk of 
cancer.  The silencing of the Wnt regulator Dickkopf-1 (DKK-1) may be another factor in 
increased colorectal cancer risk.  DKK-1 acts as a negative feedback to the Wnt pathway 
and causes increased degradation of β-catenin.  A study has shown that DKK-1 
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inactivation by hypermethylation causes an increased risk of colorectal cancer due to this 
loss of an autoregulatory mechanism in the Wnt pathway (Gonzalez-Sancho et al., 2005). 
E-cadherin and β-Catenin 
 E-cadherin is a transmembrane protein that contains an extracellular domain that 
binds with the extracellular domain of E-cadherin displayed by neighboring cells.  It is 
primarily responsible for cell-cell adhesion in epithelial cells.  E-cadherin also mediates 
the formation and organization of distinct cell junctions (Gottardi et al., 2001).  E-
cadherin controls cell growth through interactions with neighboring cells and through 
direct transduction of growth inhibitory signals. 
 The E-cadherin protein also affects cellular growth through interactions with the 
Wnt signaling pathway.  The cytoplasmic domain of E-cadherin complexes with α- and 
β-catenin.  E-cadherin is able to affect Wnt signaling by altering the amounts of free β-
catenin in the cytoplasm (Prange et al., 2003). The loss of E-cadherin causes β-catenin to 
be released from the cell junctions and then allows β-catenin to translocate to the nucleus.  
This has been shown to cause an increase in Wnt signaling. (Kuphal el al., 2005). 
 Alternatively, increasing the expression of E-cadherin leads to reduced Wnt 
signaling.  E-cadherin actively competes with TCF/LEF-1 to bind β-catenin, which 
causes a decrease in LEF-1/β-catenin dependent transcription (Ki et al., 2008).  Studies 
have shown that overexpression of E-cadherin will antagonize β-catenin and prevents its 
nuclear signaling (Gottardi et al., 2001). 
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The Wnt Pathway and AKT 
 AKT overexpression was demonstrated to be an early event in sporadic colorectal 
carcinogenesis (Roy et al., 2002).  The stabilization of β-catenin through APC mutations 
can increase transcription of AKT, a target gene of β-catenin.  AKT kinases have diverse 
functions including the regulation of cell cycle, cell survival, and apoptosis.  In normal 
colon cells, AKT activity is not significant, whereas there is an upregulation of AKT in 
colorectal cancer.  AKT was shown to be regulated by β-catenin when overexpression of 
AKT was found to correlate with overexpression/increased nuclear localization of β-
catenin.  AKT affects Wnt signaling by complexing with Axin, GSK-3β, and Disheveled, 
which helps to increase levels of free β-catenin.  Since AKT was found to affect Wnt 
signaling through the disruption of the complex that targets β-catenin for proteosomal 
degradation,  it would result in a positive feedback loop that could increase Wnt signaling 
and increase cell survival (Dihlmann et al., 2005).  The phosphorylation of AKT has also 
been shown to be an important factor in colorectal cancer.  A study has shown that 
increased activation of AKT through phosphorylation suppresses apoptosis and promotes 
cell growth (Itoh et al., 2002). 
  Linking Folate Deficiency, Wnt Signaling, and E-cadherin to Cancer 
 As previously discussed, folate deficiency may increase risk of cancer by altered 
DNA methylation, increased DNA damage, and impaired DNA repair.  Folate deficiency 
is known to cause DNA mutations in cell cycle genes, such as p53, through uracil 
misincorporation and other chromosome aberrations.  These genes important for cell 
cycle regulation have been shown to be affected by folate status (Crott et al., 2008). 
 11 
There is also evidence showing that folate deficiency is affecting the expression of genes 
involved in cell adhesion, migration, and growth.   
Of particular relevance are studies indicating that folate deficiency alters Wnt 
signaling.  Several microarray studies have shown altered expression of genes involved in 
Wnt signaling due to folate deficiency.  One microarray study showed that in normal 
human fibroblasts grown for 7 days in folate deficient medium, changes in Wnt genes 
DKK1, WISP1, and WNT5A were detected (Katula et al., 2007).  These genes are all 
important regulators of Wnt signaling and are important in regulating cell development 
and replication.  A second microarray study showed that in several normal human colon 
epithelial cell lines grown in folate deficient medium for 30 days, there were varying 
changes in Wnt genes β-catenin, APC, and E-cadherin detected between the different cell 
lines (Crott et al., 2008).  Another microarray study showed in a mouse model there was 
a decrease in APC expression and an increase in β-catenin expression in the mice due to 
folate deficient diets along with a deficiency in other B vitamins (Liu et al., 2008). More 
recently, a study performed in this lab has shown that folate deficiency causes increased 
nuclear localization and activation of β-catenin.  Together these findings suggest folate 
deficiency leads to alterations in Wnt signaling, which may contribute to increased cancer 
risk. 
 There is evidence that folate deficiency also affects levels of E-cadherin.  E-
cadherin acts as a tumor suppressor protein and has been implicated in early and late 
stages of tumor progression (Gottardi et al., 2001).  Studies have shown that levels of E-
cadherin mRNA were decreased in colon epithelial cells under folate deficient conditions 
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(Crott et al., 2008).  The deregulation of the cadherin cell adhesion system is frequently 
seen in aggressive and invasive cancers.  The invasive fronts of colorectal tumors exhibit 
reduced levels of E-cadherin expression (Kuphal et al., 2005).  In colorectal cancer, 
tumor progression is associated with accumulation of β-catenin and a loss of membranous 
E-cadherin.  However, there is a low incidence of E-cadherin mutations related to 
colorectal cancer.  Hypermethylation of the E-cadherin promoter may be a cause of 
decreased E-cadherin protein expression (Lugli et al., 2006).    These changes in E-
cadherin expression can alter cell signaling through affecting proteins involved in cancer 
progession and metastasis, such as urokinase and β-catenin (Crott et al., 2008).  It has 
been also been shown that E-cadherin proteins lacking a β-catenin binding domain did 
not suppress growth (Gottardi et al., 2001).  This could indicate that altered expression or 
possible mutations in E-cadherin would cause cancer by affecting Wnt signaling. 
 Based upon these findings, an additional mechanism for how folate deficiency 
increases the risk of colorectal cancer involves a decrease in E-cadherin protein with an 
accompanying increase in free β-catenin. 
Project Overview 
 In this study the effects of folate deficiency on E-cadherin and β-catenin were 
analyzed in two colon epithelial cell lines (Caco-2 and FHC).  E-cadherin and β-catenin 
protein levels, E-cadherin transcript levels, and the cellular localization of both E-
cadherin and β-catenin were determined in cells grown in folate sufficient and deficient 
medium.  The protein levels of several proteins in the AKT pathway were also 
determined in Caco-2 cells grown in folate sufficient and deficient medium.  Finally, the 
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transcript levels of two folate transporters, FolR-1 and RFC, were determined in cells 
grown in folate sufficient and deficient medium. 
 This study is significant as it provides provides further understanding of the 
mechanism by which folate deficiency increases the risk of cancer and other health 
problems.  Folate deficiency is one of a select few dietary components shown to be 
associated with many health conditions.  This study also helps to show that these cells 
have mechanisms that allow them to adapt to folate deficiency.  The mechanisms for all 
of these associations are still not fully understood.      
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CHAPTER II 
 
MATERIALS AND METHODS 
 
 
 
Cell Culture in Folate Sufficient and Deficient Medium 
 
FHC cells were obtained from American Type Culture Collection (ATCC).  These 
cells were initially plated in a T-25 flask using Delbecco’s Modified Eagle’s Medium 
(DMEM)/Ham’s Nutrient Mixture F-12.  DMEM/F-12 Complete Medium was prepared 
with and without folate.  The base medium was prepared at NIEHS.  The medium was 
then supplemented with 10% fetal bovine serum, 10 ng/mL cholera toxin, 5 µg/mL 
insulin, 5 µg/mL transferrin, 100 ng/mL hydrocortisone, 10% sodium bicarbonate, 0.2 M 
L-glutamine, 0.5 mM sodium pyruvate, and 10 mM HEPES.  The cells were split once 
they reached 60-70% confluency.  The cells were collected for replating using 0.25% 
Trypsin, 1mM EDTA in Hank’s salt (Millipore Cat. #SM2003C).  The cells were grown 
in a 37o C and 5% carbon dioxide incubator.  The medium was changed after four days 
and the cells were replated into new T-75 flasks and 100 mm dishes at a density of 3x105 
and 2.3x105 cells, respectively.  The cells were then grown for 30 days in folate sufficient 
and deficient medium.  The cells were replated in 100 mm dishes for protein and RNA, 
24 well plates for immunofluorescence, and 6 well plates for growth curves several days 
prior to collection at days 15 and 30.  Cells were collected at days 15 and 30 by both 
scraping and trypsinization. 
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Caco-2 cells were initially plated in a T-75 flask using RPMI 1640 Complete 
Medium (Sigma Cat. #R8758) until the cells reached 80% confluency.  The cells were 
collected for replating by trypsinization using 0.25% Trypsin, 1mM EDTA in Hank’s 
salt.  The cells were plated at a density of 7.5x105 cells per T-75 flask and 5.8x105 cells 
per 100mm dish in RPMI 1640 Complete (Sigma Cat. #R1145), with or without folate.  
The cells were grown in a 37oC and 5% carbon dioxide incubator.  The cells are then 
grown for 30 days in folate sufficient and deficient medium. The cells were replated in 
100 mm dishes for protein and RNA, 24 well plates for immunofluorescence, and 6 well 
plates for growth curves several days prior to collection at days 15 and 30.  Cells were 
collected at days 15 and 30 by both scraping and trypsinization. 
Flow Cytometry 
Caco-2 cells were collected by trypsinization in 1x PBS and pelleted.  The cells 
were resuspended in 1x PBS and pelleted again.  The cells were then fixed with 2 mL of 
100% ice cold methanol while vortexing.  The cells were later pelleted, resuspended in 1x 
PBS, and pelleted again.   The cells were resuspended in PI staining solution (5 µL 10 
mg/mL propidium iodide, 10 µL 10 mg/mL RNase A, 1 mL 1x PBS) and left in the dark 
for 30 minutes prior to analysis using a BD FACSCalibur flow cytometer. 
  Nuclei were isolated from FHC cells before PI staining.  FHC cells were released 
by trypsinization and pelleted by centrifugation.  The pelleted cells were washed in 1x 
PBS and resuspended in cold nuclear lysis buffer (320 mM Sucrose, 5 mM MgCl2, 10 
mM HEPES, 1% Triton X-100, at pH 7.4) and left on ice for 15 minutes.  The nuclei 
were pelleted and resuspended in 1x PBS with 0.25% Tween-20.  The nuclei were 
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pelleted again and resuspended in PI staining solution and left in the dark for 30 minutes 
prior to analysis on the flow cytometer. 
Folate Assay 
 The intracellular concentration of folate in both Caco-2 and FHC cells was 
determined using a standard microtiter plate assay utilizing Lactobacillus casei (Tamura, 
1990).  Caco-2 and FHC cell pellets were resuspended in 200 µL of an extraction buffer 
(50 mM Tris, 1mM EDTA at pH 7.4 and 1% ascorbic acid).  The extracts were spun at 
10k and 4oC for 10 minutes.  The extracts were boiled for 5 minutes and centrifuged at 
10k for 5 minutes.  The supernatant was placed into a new microcentrifuge tube and 
placed on ice.  Varying amounts (10 µL to 50 µL) of this cellular extract was added to a 
96 well plate in a 0.2 M phosphate buffer and 0.1% ascorbic acid buffer.  Then 10 µL of 
a 10% dilution of L.casei bacteria in 0.9% NaCl was added to each well along with 150 
µL of L. casei medium containing no folate.  A standard curve (20 pg to 800 pg) was 
prepared using folinic acid.  The plate was allowed to incubate overnight at 37oC.  The 
plate was then read on a Bio-Tek Synergy HT microplate reader at 660 nm.  Folate 
concentrations were obtained by utilizing the folinic acid standard curve.  
Protein Quantification 
 
 Caco-2 and FHC cells used for protein quantification were collected via scraping.  
500 µL of 2x SDS lysis buffer was added to each 100 mm dish along with 5 µL of 100 
mM Na3VO4, 2.5 µL of 1 M DTT and 70 µL 7x Protease Inhibitor.  The samples were 
sonicated and placed on ice.  The Pierce 660 nm Protein Assay was used to determine the 
amount of protein in the samples, using a 96 well format.  The plates were read on a Bio-
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Tek Synergy HT microplate reader at 660 nm.  The protein concentrations were obtained 
by utilizing a standard curve using known quantities of bovine serum albumin (BSA). 
Western Blot 
 
 Caco-2 and FHC cells used for Western blot analysis were collected by scraping 
cells at different days of folate deficiency.  Cells grown in 100 mm dishes were lysed 
using 2xSDS, 100 mM Na3VO4, 1 M DTT, and 7x Protease Inhibitor.  The samples were 
stored at –80oC.  When ready for analysis, the samples were allowed to thaw, sonicated, 
and placed on ice.  The protein content of the samples were determined as previously 
described with the Pierce 660 nm Protein Assay. 
 An equal amount of cellular protein from each folate sufficient and deficient 
sample was loaded into separate wells of a 6% SDS-PAGE gel.  Color protein markers 
(Prosieve, Cat. #50550) were loaded into one lane of the gel.  After electrophoresis, the 
protein was transferred onto nitrocellulose using standard methods.  The blot was stained 
using Ponceau S to visualize the proteins and confirm that the samples were loaded 
equally.  The blot was blocked in 5% milk in Tween-Tris Buffered Saline (TTBS) (0.15 
M NaCl, 0.01 M Tris pH 8.0, 0.5% Tween) for one hour.  For Caco-2 cells, a 1:1,000 
dilution of rabbit anti-E-Cadherin antibody (Cell Signaling Technology Cat. # 4065) in 
5% BSA in TTBS was added to the blots and left overnight.  For FHC cells mouse anti-
human E-cadherin (Takara Cat. # M106) was used.  A 1:1,000 dilution of mouse anti-β-
catenin antibody (Invitrogen Cat. #13-8400) in in 5% BSA in TTBS was added to the 
blots and left overnight.  A 1:200 dilution of mouse anti-Tubulin (Developmental Studies 
Hybridoma Bank) in 1% milk in TTBS was added to the blots and left overnight.  Also, 
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1:1,000 dilutions of anti-rabbit phospho-AKT (Thr 308), phospho-AKT (pan), phospho-
GSK-3β, phospho-PTEN, phospho-PDK1, and phospho-c-Raf (Cell Signaling 
Technology Cat. # 9916) were added to the blots and left overnight with a 1:200 dilution 
of mouse anti-Tubulin.  The following day, the nitrocellulose was washed in TTBS three 
times for five minutes per wash and once for 15 minutes.  A 1:10,000 dilution of horse 
radish peroxidase in 1% milk in TTBS was placed on the nitrocellulose for one hour.  
The nitrocellulose was washed three times in TTBS for 5 minutes per wash and once for 
15 minutes.  The Supersignal West Pico-Substrate detection kit (Thermo-Scientific Cat. # 
34080) was used to detect the antibody on the nitrocellulose.  The imaging of the blots 
was performed using the BioRad Chemi Doc XRS imager using the Quantity One 
software. 
Immunofluorescence 
 
 Caco-2 and FHC cells used for immunofluorescence were grown on round glass 
coverslips in 24 well plates.  The cells in each well were directly fixed with 1 mL of 2% 
paraformaldehyde in 1x PBS for 15 minutes at room temperature.  After fixation, the 
cells were washed three times with 500 µL PBS for five minutes per wash.  The cells 
were stored in 1 mL 1x PBS at 4o C. 
 The cells on each disk were permeabilized with 400 µL of 0.25% Triton X-100 in 
1x PBS for 5 minutes, and then washed three times with 500 µL PBS for 5 minutes per 
wash.  For Caco-2 cells, a combined 65 µL of primary antibodies, mouse anti-β-catenin 
(Invitrogen Cat. #13-8400) and rabbit anti-E-cadherin (Cell Signaling Technology Cat. # 
4065) diluted 1:100 each were added directly onto each coverslip and incubated at 37o C 
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for 90 minutes.  For FHC cells, a combined 65 µL of primary antibodies, rabbit anti-β-
catenin (Millipore Cat. #AB19022) and mouse anti-human E-cadherin (Takara Cat. 
#M106)  After incubation, the cells were washed three times with 500 µL PBS for 5 
minutes per wash.  Then a combined 95 µL of secondary antibodies, goat anti-mouse IgG 
with fluoroform Alexa 488 (Invitrogen, Cat. #A11001) and donkey anti-rabbit IgG with 
fluoroform Alexa 594 (Invitrogen, Cat. #A21207), diluted 1:400 were then added directly 
to each coverslip.  The cells were shielded from light and incubated at room temperature 
for 90 minutes.  The cells were washed four times with 500 µL PBS for 5 minutes per 
wash.  The coverslips were then mounted onto glass slides using DakoCytomation 
Fluorescent Mounting Medium and analyzed using confocal microscopy. 
RNA Isolation and Real Time PCR 
 RNA was isolated from cell samples using the SV Total RNA Isolation Kit 
(Promega Cat. #23100).  The RNA was converted to cDNA using the Omniscript RT Kit 
(Qiagen Cat. #205110).  qRT-PCR was conducted using the Taqman Gene Expression 
Master Mix (Applied Biosystem Cat. # 4369016) and Applied Biosystem gene specific 
primers for E-cadherin (Applied Biosystem Cat. #Hs01013953_m1), FolR-1 (Applied 
Biosystem Cat. #Hs00360501_m1), and RFC (Applied Biosystem Cat. 
#Hs00953344_m1) using the Applied Biosystems StepOne real time PCR system.  Three 
reactions were conducted for each primer.  Glyceraldehyde 3-phosphate (GAPDH) 
(Applied Biosystem Cat. #Hs99999905_m1) was used as the internal control. 
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CHAPTER III 
 
RESULTS 
 
 
Cell Proliferation in Folate Sufficient and Deficient Medium 
 It was previously shown in this lab that folate deficiency alters cell growth rates 
and cell cycle phase distribution in NIH3T3 cells.  Folate deficiency resulted in decreased 
cell proliferation rates and an increase in the percentage of cells in S phase of the cell 
cycle (unpublished data).  As colon epithelial cell lines (Caco-2 and FHC) were used in 
these studies, it was necessary to investigate the effects of folate deficiency on the growth 
rate and the cell cycle of these cells.  Published data has shown that various cell types, 
including intestinal epithelial cells, can adapt biochemically to folate deficiency (Crott et 
al., 2008; Subramanian et al., 2003; Sadasivan et al., 2002), but no data is currently 
available on growth rates and cell cycle for either cell lines. 
 Caco-2 is a transformed human adult colon epithelial cell line and FHC is a 
normal human fetal colon epithelial cell line.  Morphologically the two cell lines appear 
similar, however they behave differently.  FHC cells grow slower than Caco-2 cells.  
FHC cells also adhere to the culture plate overnight after trypsinization, whereas Caco-2 
cells require one to two days to reattach.  
Cell number was controlled by collecting, counting, and aliquoting equal cell 
numbers for both folate sufficient and deficient cells. 
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 Caco-2 cells grown under folate sufficient and deficient conditions were replated 
at equal cell number on day 15 then collected and counted over the next 6 days (Figure 
3A).  Six days after replating a reduction in cell number was detected for cells grown 
under folate deficient conditions.  A second growth curve for Caco-2 cells beginning at 
day 30 was conducted (Figure 3B).  Caco-2 cells grown under folate deficient conditions 
for 10 days after replating at day 30 showed reduced rates of proliferation.  At day 40 the 
cell number was 2.1x105 for folate sufficient cells compared to 5.3x104 for folate 
deficient cells.  During the next 10 days (day 40 to day 50), the growth rate of folate 
deficient cells increased and was more similar but slightly less than the folate sufficient 
cells.   
 
 
Figure 3:  Growth curves for Caco-2 cells grown under folate sufficient (With) and 
deficient (No) conditions.  A) Caco-2 cells grown for 15 days in With/No medium and 
replated on day 15.  Cells were collected and counted at the indicated time points.  B) 
Caco-2 cells grown for 30 days in With/No medium and replated at 30 days.  Cells were 
collected and counted at the indicated time points. 
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 For FHC cells grown under folate sufficient and deficient conditions, the growth 
curve beginning at day 15 was comparable to the Caco-2 cells (Figure 4A).  Five days 
after replating at the same cell number at day 20 FHC cells continued to proliferate at a 
normal rate under folate deficient conditions, although a little slower than the folate 
sufficient cells.  However, the proliferation rate of the folate deficient cells decreased 
between days 20 and 25 after replating in comparison to the folate sufficient cells.  A 
second growth curve for FHC cells beginning at day 30 showed a similar trend to Caco-2 
(Figure 4B).  After the cells were allowed to grow for another 20 days in folate sufficient 
and deficient medium, the folate deficient cells continued to proliferate but at a lower rate 
than the folate sufficient cells. 
 
 
Figure 4:  Growth curves for FHC cells grown under folate sufficient (With) and 
deficient (No) conditions.  A) FHC cells grown for 15 days in With/No medium and 
replated on day 15.  Cells were collected and counted at the indicated time points.  B) 
FHC cells grown for 30 days in With/No medium and replated at 30 days.  Cells were 
collected and counted at the indicated time points. 
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Effects of folate deficiency on the cell cycle 
 Cell cycle analysis was performed on both Caco-2 and FHC cells to determine the 
effects of folate deficiency on cell cycle phase distribution.  Caco-2 cells were collected 
at days 15 and 30. FHC cells were collected at day 30 and 70.  Whole cells for Caco-2 
cells and isolated nuclei for FHC cells were analyzed for DNA content using a flow 
cytometer (Figure 5). 
                     
 
 
Figure 5:  Cell cycle phase distribution of Caco-2 and FHC cells grown under folate 
sufficient (With) and deficient (No) conditions.  A) Caco-2 cells grown for 15 and 30 
days in With/No medium.  Cells were collected, counted, fixed with 100% methanol, and 
stained with propidium iodide at indicated time points.  B) FHC cells grown for 30 and 
70 days in With/No medium.  Cells were collected, nuclei were isolated, and stained with 
propidium iodide at the indicated days.  Samples were analyzed using a BD FACSCalibur 
flow cytometer.  M1: G1 phase; M2: S phase; M3:G2/M phase.  (Figure continued on next 
page) 
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Figure 5 (continued) 
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Table 1:  Cell cycle phase distribution of Caco-2 and FHC cells grown under folate 
sufficient and deficient conditions.  The percentage for each phase was obtained from 
the values for M1, M2, and M3 as shown in Figure 5.  W: with folate; N:  no folate 
 
  
Caco-2 
Day 15 
W 
 
 
Caco-2 
Day 15 
N 
 
Caco-2 
Day 30 
W 
 
Caco-2 
Day 30 
N 
 
FHC 
Day 30 
W 
 
FHC 
Day 30 
N 
 
FHC 
Day 70 
W 
 
FHC 
Day 70 
N 
 
G0/G1 
(M1) 
 
 
65.6% 
 
54.9% 
 
65.4% 
 
52.2% 
 
70.9% 
 
71.7% 
 
76.9% 
 
74.3% 
 
S 
(M2) 
 
 
11.3% 
 
16.6% 
 
9.7% 
 
18.4% 
 
5.8% 
 
6.5% 
 
3.5% 
 
3.5% 
 
G2/M 
(M3) 
 
 
23.1% 
 
28.5% 
 
24.9% 
 
29.4% 
 
18.9% 
 
18.8% 
 
 
19.6% 
 
22.2% 
    
 
 
 At day 15 for Caco-2 cells, there was a greater percentage of cells in S phase in 
folate deficient cells (16.6%) as compared to folate sufficient cells (11.3%).  There was 
also an increase in the cells in G2/M phase in folate deficient cells (28.5%) as compared 
to folate sufficient cells (23.1%).  At day 30 for Caco-2 cells, there was a higher 
percentage of cells in S phase in folate deficient cells (18.4%) than in folate sufficient 
cells (9.7%).  The percentage of cells in G2/M phase was also higher in folate deficient 
cells (29.4%) at day 30 than folate sufficient cells (24.9%) (Table 1).  These results 
suggest that the cell cycle phase distribution of Caco-2 cells is being affected by folate 
deficiency after 15 days, and continues to be affected in a similar way after 30 days.   
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In FHC cells, after 30 days the percentage of cells in each cell cycle phase was 
similar for both folate sufficient and deficient cells.  In an attempt to elicit a response to 
folate deficiency in FHC cells we cultured the cells for 70 days in folate sufficient and 
deficient medium.  Even after this extended period of time we saw no change in cell 
cycle distribution.  These results demonstrate that the cell cycle phase distribution of 
FHC cells is not affected by folate deficiency, unlike Caco-2 cells. 
Intracellular Detection of Folate 
 A standard folate assay utilizing L. casei bacteria was performed on Caco-2 and 
FHC cells grown under folate sufficient and deficient conditions (data not shown).  This 
was done to determine if the intracellular levels of folate were reduced in Caco-2 and 
FHC cells grown in folate deficient medium.  The levels of folate were undetectable in 
Caco-2 and FHC cells grown under folate deficient conditions.  The level of intracellular 
folate was detectable in Caco-2 cells (409 pg) and FHC cells (14.5 pg) grown under 
folate sufficient conditions.  Cell number was determined for Caco-2 cells (4x106 cells) 
but not for FHC cells, hence it is not possible to compare these values.  Our results are 
what would be expected considering that no folate was added to the deficient medium 
during preparation.  However, some folate may still be present in the dialyzed serum used 
in both folate sufficient and deficient medium.  This could explain the continued 
proliferation of both Caco-2 and FHC cells even under folate deficient conditions. 
E-cadherin and β-catenin Protein Levels 
 There is supporting evidence showing that E-cadherin and β-catenin protein levels 
are affected by folate deficiency (see Background).  β-catenin has been shown to 
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associate with membrane-bound E-cadherin and is part of a complex that anchors E-
cadherin to the cytoskeleton.  Any alterations in E-cadherin protein could cause a change 
in the level of free cytoplasmic β-catenin. 
 A western blot analysis was performed to determine if folate deficiency leads to 
any change in E-cadherin and β-catenin protein levels.  Caco-2 and FHC cells were 
grown for 15 and 30 days in folate sufficient and deficient medium.  Protein lysates were 
prepared and analyzed by western blot.  The detected bands were quantified and 
standardized to tubulin protein. 
 E-cadherin and β-catenin protein levels in Caco-2 cells grown for 15 and 30 days 
in folate sufficient and deficient medium was determined by western blot analysis (Figure 
6).   
 
 
Figure 6. Western blot detection of E-cadherin, β-catenin, and Tubulin in Caco-2 
cells.  Caco-2 cells were grown for 15 and 30 days in folate sufficient and deficient 
medium.  Protein lysates were prepared and 50µg of each lysate was electrophoresed on a 
6% SDS-PAGE gel.  W: with folate; N: no folate. 
 
 
At day 15 and 30, there was a decrease in E-cadherin protein in folate deficient 
cells as compared to folate sufficient cells (Figure 7A).  The protein levels of β-catenin 
decreased at both day 15 and day 30 in the folate deficient cells (Figure 7B). 
 
E-cadherin (120 kD) 
    β-catenin (96 kD) 
      Tubulin (50 kD) 
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Figure 7. Relative Protein Levels of E-cadherin and β-catenin in Caco-2 cells.  
Relative protein levels of E-cadherin and β-catenin in Caco-2 cells grown for 15 and 30 
days in folate sufficient and deficient medium.  Relative protein levels of A) E-cadherin 
and B) β-catenin was determined by standardizing to tubulin.  Values represent the 
average of two technical repeats.  Values above bars represent values for each trial (Top: 
Trial 1, Bottom: Trial 2). 
 
 E-cadherin and β-catenin protein levels in FHC cells grown for 15 and 30 days in 
folate sufficient and deficient medium were also determined by western blot analysis 
(Figure 8).  For FHC cells, a different E-cadherin antibody was used because the E-
cadherin antibody used for Caco-2 cells did not detect FHC E-cadherin.   
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Figure 8. Western blot detection of E-cadherin, β-catenin, and Tubulin in FHC cells.  
FHC cells were grown for 15 and 30 days in folate sufficient and deficient medium.  
Protein lysates were prepared and 25µg of lysates were electrophoresed on a 6% SDS-
PAGE gel.  W: with folate; N: no folate. 
 
 
At day 15, there was a decrease in E-cadherin protein in folate deficient cells as 
compared to folate sufficient cells.  At day 30, there was no change or possibly a small 
increase in E-cadherin protein due to folate deficiency (Figure 9A).  The protein level of 
β-catenin decreased at day 15 due to folate deficiency, but there was no change at day 30 
(Figure 9B). 
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Figure 9. Relative Protein Levels of E-cadherin and β-catenin in FHC cells. Relative 
protein levels of E-cadherin and β-catenin in FHC cells grown for 15 and 30 days in 
folate sufficient and deficient medium.  Relative protein levels of A) E-cadherin and B) 
β-catenin was determined by standardizing to tubulin. 
 
Additional biological replicas of these western blots are needed to verify these 
results and determine statistical significance. 
E-cadherin Transcript Levels in Folate Sufficient and Deficient Cells 
 Our analysis suggests that E-cadherin protein levels are slightly decreased in 
folate deficient cells at the earlier time points for both Caco-2 and FHC cells.  To 
determine if folate deficiency leads to alterations in E-cadherin mRNA, qRT-PCR was 
performed using Caco-2 and FHC cells.  Caco-2 and FHC cells were grown in folate 
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sufficient and deficient medium and cells were collected for RNA isolation at days 15 
and 30.  The RNA was converted to cDNA and analyzed using primers specific for E-
cadherin and GAPDH.  The E-cadherin cycle values were normalized to the cycle values 
for GAPDH.  Then, the relative change was determined by dividing the normalized cycle 
values for folate deficient samples by the value for the folate sufficient samples.  At day 
15, the E-cadherin transcripts were unaffected by folate deficiency.  At day 30, the level 
of E-cadherin transcripts was reduced in comparison to folate sufficient cells by 
approximately one half (Figure 10). 
 
 
 
 
Figure 10.  Relative change in E-cadherin transcripts in Caco-2 cells.  E-cadherin and 
GAPDH primers were used to amplify the target cDNAs prepared from RNA isolated 
from Caco-2 cells grown for 15 and 30 days in folate sufficient and deficient medium.  E-
cadherin transcript levels were normalized to GAPDH and the relative change 
determined. 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Day 15 Day 30
Re
la
ti
ve
 C
ha
ng
e 
in
 E
-c
ad
he
ri
n 
Tr
an
sc
ri
pt
s
32 
 
 We were unable to amplify the E-cadherin transcripts using RNA isolated from 
FHC cells and two distinct E-cadherin primer sets.  This is likely due to these cells 
having a distinct fetal E-cadherin transcript. 
E-cadherin and β-catenin Localization 
 We found a slight decrease in E-cadherin and β-catenin protein levels due to 
folate deficiency in Caco-2 cells at days 15 and 30.  We also found a decrease in both 
proteins in FHC cells at day 15, but relatively no change in E-cadherin protein levels at 
day 30 and no change in β-catenin protein levels.  We then wanted to determine if the E-
cadherin/β-catenin complex that anchors E-cadherin to the cytoskeleton was affected by 
folate deficiency.  A decrease in E-cadherin would be expected to lead to a reduced 
membrane association of β-catenin.  Cellular localization of both proteins was examined 
using immunofluorescence. 
 Caco-2 and FHC cells were grown in folate sufficient and deficient medium for 
15 days.  The cells were plated onto coverslips, and fixed 5 days later (day 20).  This was 
done to allow the Caco-2 cells ample time to attach.  The cells were immunostained for 
E-cadherin and β-catenin with each having its own distinct fluorophore.  The cells were 
then analyzed using a confocal microscope (Figure 11). 
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(Figure Legend on next page) 
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Figure 11: Immunofluorescent staining for E-cadherin and β-catenin in Caco-2 and 
FHC cells.  A) Immunofluorescent staining of Caco-2 cells grown for 20 days in folate 
sufficient (With) and deficient (No) medium.  B) FHC cells grown for 20 days in folate 
sufficient (With) and deficient (No) medium.  Cells were immunostained for E-cadherin 
(red) and β-catenin (green).  Overlap of both proteins is shown in yellow. 
 
 
 In Caco-2 cells, at day 20 we see that E-cadherin and β-catenin are diffuse in 
folate sufficient cells.  The merged image shows an overlap of these two signals due to 
the yellow color produced by the overlap of the red and green fluoroforms, which 
demonstrates that these two proteins are found in the same areas throughout the cells.  In 
the folate deficient cells at day 20 we see a similar staining pattern for E-cadherin when 
compared to the folate sufficient cells.  We do, however, see a difference in β-catenin in 
the folate deficient cells.  There is increased staining of β-catenin at the cell membrane in 
the folate deficient cells, but it also remains diffuse throughout the cells.  When the 
images are merged the red (E-cadherin) and green (β-catenin) are distinct and display less 
overlap in the folate deficient cells when compared to the folate sufficient cells.  There is 
an increase in β-catenin localization at the cell membrane shown by the increase in the 
green color at the membrane which is associated with β-catenin, whereas the localization 
of E-cadherin remains unchanged (Figure 11A).  
 In FHC cells, at day 20 we see that both E-cadherin and β-catenin are diffuse 
throughout the cells under folate sufficient conditions.  The merged image shows an even 
overlap of these proteins.  In the folate deficient cells we see that both E-cadherin and β-
catenin remain diffuse throughout the cells.  We also see that there is an increase in 
nuclear staining for both proteins.  The merged image shows a nearly perfect overlap 
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between the two colors in both folate sufficient and deficient cells.  This holds true for 
the signals for both proteins found in the nuclei of the folate deficient cells (Figure 11B). 
AKT Pathway Protein Levels in Folate Sufficient and Deficient Cells 
 In an effort to understand why folate deficient cells continued to cycle we looked 
to see if the AKT pathway may be affected.  Since the AKT pathway is important for cell 
survival during stress and cell growth regulation, this pathway seemed a likely candidate 
to help explain how the cells were able to seemingly adapt to folate deficiency. 
 Caco-2 cells were used to test if the AKT pathway was affected by folate 
deficiency.  The cells were grown for 15 and 30 days in folate sufficient and deficient 
medium.  The cells were collected and cell lysates prepared for Western Blot analysis.  
The most commonly activated form of AKT, phospho-AKT (Thr 308), was analyzed via 
western blot and compared to the total amount of AKT protein present (Figure 12). 
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Figure 12:  Relative phospho-AKT (Thr 308) protein levels in Caco-2 cells. Relative 
protein levels of phospho-AKT (Thr 308) in Caco-2 cells grown for 30 days in folate 
sufficient and deficient medium.  Relative protein levels determined by standardizing to 
total AKT protein. 
 
 
 The level of phosphorylated AKT was decreased slightly due to folate deficient 
conditions at day 15.  There was a minor increase in phosphorylated AKT after the cells 
were grown for 30 days in folate deficient medium.  These results demonstrate that there 
is no major increase in the activation of AKT due to folate deficiency, although the 
increase at day 30 cannot be discounted.  Additional biological replicas will need to be 
carried out to determine if these small changes may be significant. 
 To gain further insight into any possible effect of folate deficiency on the AKT 
pathway, we examined whether other proteins in the AKT pathway were altered due to 
folate deficiency.  Caco-2 cells grown for 30 days in folate sufficient and deficient 
medium were analyzed via western blot to detect the levels of phospho-GSK-3β, 
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phospho-c-RAF, phospho-PDK1, phospho-PTEN (Figure 13).  All of these proteins are 
important downstream effectors of the AKT pathway. 
 
 
 
Figure 13:  Relative Protein Levels of phospho-GSK-3β, phospho-PDK1, phospho-c-
RAF, and phospho-PTEN in Caco-2 cells.  Relative protein levels of phospho-GSK-3β, 
phospho-PDK-1, phospho-c-Raf, and phospho-PTEN in Caco-2 cells grown for 30 days 
in folate sufficient and deficient medium.  Relative protein levels determined by 
standardizing to Tubulin. 
 
 
 The results of this experiment show that after the Caco-2 cells are grown for 30 
days in folate deficient medium there is a slight decrease in the phosphorylated protein 
levels of phospho-PDK-1 and phospho-c-Raf, and likely no change in phospho-PTEN 
phospho-GSK-3β.  Again, it has not been demonstrated that these small changes are 
significant. 
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Transcripts Levels of Folate Transporters 
We found that both Caco-2 and FHC cells continued to grow under folate 
deficient conditions.  Upon review of the literature (see Discussion), we found published 
studies supporting our observation that colon epithelial cells can adapt to folate 
deficiency.  Moreover, there is data indicating that the molecular basis for this adaptation 
is an increase in various folate transporters.  To determine if similar molecular changes 
are occurring in our two cells lines, the transcript levels of two folate transporters were 
quantified. 
A common folate receptor found in both cell lines was the Reduced Folate Carrier 
(RFC).  We used quantitative real time PCR to determine if there was a change in the 
transcript levels of RFC in Caco-2 and FHC cells due to folate deficiency.  Caco-2 cells 
were grown for 15 and 30 days in folate sufficient and deficient medium.  FHC cells were 
grown for 15, 30, and 70 days in folate sufficient and deficient medium.  The RNA was 
isolated, converted to cDNA, and analyzed using primers specific for RFC and GAPDH.  
The RFC values were normalized to GAPDH and the relative change was determined by 
dividing the normalized folate deficient samples by the folate sufficient samples.   
In Caco-2 cells there was essentially no change in RFC transcripts due to folate 
deficiency at day 15.  However, at day 30 there was greater than a 2.5-fold increase in 
RFC transcripts in folate deficient cells when compared to folate sufficient cells (Figure 
14A). 
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Figure 14: Relative change in RFC transcripts in Caco-2 and FHC cells.  A) RFC and 
GAPDH primers were used to amplify the target cDNAs prepared from RNA isolated 
from Caco-2 cells grown for 15 and 30 days in folate sufficient and deficient medium. B) 
RFC and GAPDH primers were used to amplify the target cDNAs prepared from RNA 
isolated from FHC cells grown for 15, 30, and 70 days in folate sufficient and deficient 
medium.  RFC transcript levels were normalized to GAPDH and the relative change 
determined. 
 
 
 In FHC cells, it was shown that there was a decrease in the relative transcripts of 
RFC due to folate deficiency at day 15.  Then an incremental increase in RFC transcript 
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levels followed at days 30 and 70 in folate deficient cells when compared to the folate 
sufficient cells (Figure 14B).  However, the transcript levels for all time points are lower 
in folate deficient cells than folate sufficient cells.   
Another folate receptor, FolR-1, was analyzed using real time PCR to determine if 
it was affected by folate deficiency.  In Caco-2 cells there was an almost 2.5-fold increase 
in the relative transcript levels at day 15 in folate deficient cells when compared to folate 
sufficient cells.  Then at day 30 the transcript level was only slightly higher in the folate 
deficient cells when compared to the folate sufficient cells (Figure 15).  Again, the 
significance of these changes have not been determined. 
 
 
 
Figure 15: Relative change in FolR-1 transcripts in Caco-2 cells.  FolR-1 and GAPDH 
primers were used to amplify the target cDNAs prepared from RNA isolated from Caco-2 
cells grown for 15 and 30 days in folate sufficient and deficient medium.  FolR-1 
transcript levels were normalized to GAPDH and the relative change determined. 
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  We were unable to amplify the FolR-1 transcripts using RNA isolated 
from FHC cells.  This is likely due to these cells having a distinct fetal FolR-1 or this 
receptor is not utilized in these cells.  We also used a primer for the FolR-2 folate 
receptor, which is the reported fetal form for this class of receptors.  Again, no 
amplification was detected. 
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CHAPTER IV 
 
DISCUSSION 
 
 
 Many studies have shown a correlation between folate status and cancer risk.  The 
risk of colorectal cancer, in particular, has been linked to folate status (Kim, 2004).  
Aberrations in the Wnt signaling pathway have been shown to be involved in 90% of 
human colorectal cancers (Fodd et al., 2001) and Wnt mutations are involved in 
sporadically occurring and familial forms of colorectal cancer (Liu et al., 2007; Jin et al., 
2008).  E-cadherin can regulate Wnt signaling due to the fact that the intracellular domain 
of E-cadherin complexes with β-catenin at the cell membrane, and thus helps to control 
free cytoplasmic β-catenin (Prange et al., 2003).  The deregulation of the cell adhesion 
system is seen in invasive cancers, and a reduction in E-cadherin has been found in the 
invasive fronts of colorectal tumors (Kuphal et al, 2005).  Thus, one mechanism by which 
folate deficiency may increase the risk of colorectal cancer is by affecting E-cadherin 
levels and Wnt signaling.  Support for such a mechanism are studies showing alterations 
in E-cadherin, β-catenin, and Wnt pathway gene expression in folate deficient cells 
(Katula et al., 2007; Liu et al., 2007; Crott et al., 2008). 
The purpose of this study was to determine if folate deficiency altered the levels 
of E-cadherin and the co-localization of both E-cadherin and β-catenin in two colon 
epithelial cell lines (Caco-2 and FHC).  
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Altered cell growth and adaptation of Caco-2 and FHC cells in folate deficient medium 
 The first phase of our study was to characterize the effect of folate deficiency on 
cell proliferation and the cell cycle in both Caco-2 and FHC cells.  It was expected that 
cell proliferation would decrease under folate deficient conditions and that there would be 
an increase in the number of cells halted in S phase of the cell cycle.  Our results showed 
that both Caco-2 and FHC cells grew at a different rate under folate deficient conditions, 
but they continued to grow even after 70 days of folate deficiency for FHC cells.  This 
was unexpected as previous studies in this lab showed that fibroblastic cell lines 
essentially stop growing in folate deficient medium after 10 days.   
In Caco-2 cells it was found that the percentage of cells in S and G2/M phases 
increased due to folate deficiency, but the cells continued to cycle.  FHC cells showed no 
noticeable change in cell cycle phase distribution under folate deficient conditions.  The 
cells seemingly continued to cycle normally and showed no changes in the percentage of 
cells in any phase of the cell cycle.  This was an unexpected result.  Since Caco-2 cells 
are cancerous and FHC cells are normal the opposite results would be expected.  There 
may be some uncharacterized aspect of FHC cells, which are fetal in origin.  Alternately, 
the preparation of Caco-2 and FHC cells for DNA content analysis was different.  
Although propidium iodide was used to label the DNA, whole cells were used for Caco-2 
cells and nuclei were isolated for FHC cells.  FHC cells tend to clump after 
trypsinization, making it necessary to obtain more cells for flow cytometry, as the clumps 
of cells cannot be analyzed .  Consequently, the alternative approach of isolating nuclei 
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was tried with superior results.  To confirm that Caco-2 cell cycle is, indeed, affected by 
folate deficiency it will be necessary to repeat the flow cytometry using isolate nuclei.     
The finding that both Caco-2 and FHC cells continued to cycle suggested that the 
cells had a sufficient source of folate.  The fetal bovine serum used in the culture medium 
must be dialyzed to remove folate, although it is not possible to reduce the folate level to 
zero.  As such, we were concerned that the folate deficient medium had a higher than 
expected level of folate.  A folate determination assay on cells grown in folate sufficient 
and deficient medium confirmed that cells grown under folate deficient conditions had no 
detectable levels of folate, supporting the conclusion that both Caco-2 and FHC cells can 
continue to divide with low levels of folate.   
The continued growth of Caco-2 and FHC cells in the folate deficient medium 
was unexpected.  A literature search revealed that it has been known that intestinal and 
colon epithelial cells can adapt to folate deficiency.  One study showed that in several 
normal colonic cell lines there was an upregulation of the reduced folate carrier (RFC) 
and folate receptor 1 (FolR-1) due to folate deficiency (Crott et al., 2008).  This is more 
than likely due to the fact that one of the key physiological roles for the intestinal track is 
absorption of nutrients.  Folate is mostly absorbed in the enterocytes of the small 
intestine.  Several other studies on folate adaptation have shown similar results even in 
non-intestinal cells lines.  These studies have shown that there is an upregulation of folate 
receptors and an increase in transcript half-life (Sadasivan et al., 2002; Zhu et al., 2001; 
Subramanian et al., 2003).  To confirm these findings in Caco-2 and FHC cells, the 
transcript levels of various folate transporters were determined by qRT-PCR.  Our results 
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showed that folate deficient Caco-2 cells upregulated RFC and FolR-1.  RFC showed a 
2.5-fold increase in transcript levels in folate deficient cells at day 30.  FolR-1 showed 
about a 2.5-fold increase in transcript levels at day 15 in folate deficient cells.  However, 
the transcript levels for FolR-1 returned to normal (folate sufficient) levels at day 30.   
We found that in FHC cells there was an overall decrease in the transcript levels 
of RFC.  However, with continued days in folate deficient conditions there was an 
increase in transcript levels until the levels were comparable to that measured in folate 
sufficient cells.  This could be due to a delayed attempt by FHC cells to adapt to folate 
deficiency through maintaining normal transcript levels or increasing transcript half-life.  
It could be a combination of the two.  However, a decrease in RFC is opposite of what 
would be expected.  One issue is the internal control, GAPDH, which may not be 
appropriate for these cells due to the possibility of folate deficiency affecting glycolysis.  
The use of additional internal controls such as Actin and/or Tubulin is warranted.   
Overall, our results suggest that Caco-2 cells are adapting to folate deficiency.  
This would be the likely explanation for why Caco-2 (and perhaps FHC) cells continued 
to proliferate and cycle in folate deficient medium.  In a study using gonadotroph α3T-1 
cells an increase in FRα (FolR-1) protein was found to be associated with increased cell 
proliferation and an increased percentage of cells in S phase (Yao et al., 2009).  This 
correlates with the results we found for Caco-2 cells in that there was an increased 
percentage of cells in S phase due to folate deficiency.  The cells continued to grow as 
well, but at a slower rate than folate sufficient cells.  FHC cells showed no change in cell 
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cycle phase distribution due to folate deficiency, and also continued to grow.  We were 
unable to confirm that folate transporters increased in these cells.   
Decrease in E-cadherin and β-catenin in folate deficient Caco-2 and FHC cells 
 Since E-cadherin can regulate the levels of free cytoplasmic β-catenin, we wanted 
to determine if folate deficiency is associated with a reduction in E-cadherin protein, 
which could alter Wnt signaling.  Western blot analyses were performed to determine if 
folate deficiency led to any changes in E-cadherin and β-catenin protein levels.  In Caco-
2 cells we found that there was a decrease in E-cadherin and β-catenin protein levels at 
days 15 and 30 in folate deficient cells when compared to folate sufficient cells.  
Similarly, we found that E-cadherin and β-catenin protein levels decreased at day 15 in 
folate deficient FHC cells.  However, at day 30 in FHC cells there was an increase in E-
cadherin protein in folate deficient cells, whereas β-catenin protein levels did not change.  
These findings suggest that folate deficiency is having some effect on E-cadherin protein 
levels, and β-catenin protein levels are being affected as well.   
Various studies have shown that E-cadherin affects Wnt signaling through its 
ability to regulate the levels of free cytosolic β-catenin (Gottardi et al., 2001; Kuphal et 
al., 2005; Ki et al., 2008).  An inverse relationship between E-cadherin protein levels and 
nuclear signaling of β-catenin was found.  We found that β-catenin followed a similar 
trend as E-cadherin in overall cellular protein levels; both proteins decreased in folate 
deficient cells.  Wnt signaling may be affected, but it seems more likely that in Caco-2 
and FHC cells β-catenin levels are tightly regulated.  This could be due to the fact that as 
β-catenin protein is released from the E-cadherin adhesion complex it is immediately 
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targeted and degraded by a normally functioning degradation complex.  This would not 
give the released β-catenin an opportunity to localize to the nucleus, which could prevent 
an onset of aberrant Wnt signaling.  Moreover, the observation that β-catenin protein 
levels are slightly reduced would further indicate that the degradation process is 
enhanced.  One major issue with these data is that only one technical replica was 
performed.  Since the changes in protein were subtle, at least three biological replicas are 
necessary to determine if these changes are significant.  These replicas are currently 
being completed. 
 To determine if there were any changes in E-cadherin transcripts due to folate 
deficiency we performed qRT-PCR using both Caco-2 and FHC cells.  In one study 
showed that folate deficiency was found to affect E-cadherin expression in colon 
epithelial cells lines (Crott et al., 2008).  For two of the three cell lines a small decrease in 
E-cadherin was detected, whereas a slight increase was detected in the third cell line.  We 
found that there was no effect on transcript levels after day 15 in Caco-2 cells, but there 
was a decrease in transcripts at day 30.  This result suggests that folate deficiency is 
affecting E-cadherin gene expression, which could lead to an overall decrease in E-
cadherin protein.  Indeed, our western blot data showed a slight decrease in protein 
levels.  One possible explanation for this result is alterations in DNA methylation, 
causing the E-cadherin gene to be turned off.  One study showed that E-cadherin 
expression could be altered by hypermethylation of the E-cadherin promoter (Lugli et al., 
2007).  This is counter intuitive as it would be expected that decreases in promoter 
methylation would occur in folate deficient cells due to reduced SAM.  However, various 
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studies have found both increases and decreases in gene-specific methylation patterns due 
to folate deficiency (Esteller et al., 2001; James et al., 2002).  Our attempt to amplify E-
cadherin transcripts in FHC cells was unsuccessful.  It is likely that FHC cells express a 
distinct E-cadherin transcript.   
Localization of E-cadherin and β-catenin is altered in folate deficient cells   
 We used immunofluorescence to analyze the cellular location of E-cadherin and 
β-catenin to determine if folate deficiency was causing any effect on the E-cadherin/ β-
catenin adhesion complex.  In folate sufficient Caco-2 cells at day 20, E-cadherin and β-
catenin were diffuse throughout the cell.  In folate deficient cells the pattern of E-
cadherin staining did not change, but an increase in membrane localization of β-catenin 
was seen.  There was no apparent increase in the nuclear localization of β-catenin.  This 
was a surprising result, as any increase in β-catenin membrane localization would be 
expected to be associated with membrane-bound E-cadherin.  Studies have shown that E-
cadherin is a key regulator of cytoplasmic β-catenin available for nuclear localization, 
and affects Wnt signaling through this mechanism (Orsulic et al., 1999).  However, an 
increase in membrane-bound E-cadherin was not detected.  There may be some other 
regulatory mechanism governing β-catenin accumulation at the plasma membrane that is 
independent of E-cadherin association.  One study showed that β-catenin accumulated at 
the membrane due to activation of the Wnt pathway (Hendriksen et al., 2008).  Although 
there was no increase in nuclear β-catenin, activation of other Wnt pathway proteins may 
have occurred.  This increase in membrane associated β-catenin could be through 
interactions with members of β-catenin degradation complex such as APC and axin.   
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We found strikingly different results in FHC cells.  In folate sufficient FHC cells, 
we saw a similar localization pattern as found in Caco-2 cells.  Both E-cadherin and β-
catenin were diffuse throughout the cell and localized in the same areas.  However, in the 
folate deficient cells we saw an increase in nuclear localization of both proteins.  The 
nuclear localization of β-catenin was expected but not with E-cadherin.  This finding 
could be due to some artifact in preparing the slides, but we had also prepared slides for a 
day 30 time point and found the same results (data not shown).  There is also the 
possibility that both antibodies (anti-β-catenin and anti-human E-cadherin) are 
nonspecific and the signal detected could be some other cellular protein.  Why both 
would detect a nuclear protein and give identical staining patterns is puzzling.   
Nuclear localization of E-cadherin was unexpected.  However, there are published 
studies showing that E-cadherin may localize to the nucleus.  In one study, E-cadherin 
localized to the nucleus in most cases of Merkel cell carcinoma cells but the mechanism 
leading to this change was not determined (Han et al., 2000).  Associated with the nuclear 
localization of E-cadherin was an increase in β-catenin nuclear localization.  Since this is 
a common occurrence in this kind of cancer no correlation between E-cadherin and β-
catenin was made.  In another study increased nuclear localization of E-cadherin was also 
detected, but only when using antibodies for the cytoplasmic domain of E-cadherin 
(Chetty et al., 2008).  Since this domain of E-cadherin is what binds with β-catenin the 
authors speculated that it is possible that the cytoplasmic domain of E-cadherin is cleaved 
from the extracellular domain and “piggy-back” with β-catenin into the nucleus.  
Although FHC is a normal cell line and not cancerous, our findings support this 
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mechanism.  We found that nuclear localization of E-cadherin coincided directly with β-
catenin localization.  In fact, they overlapped perfectly.  The antibody that we used to 
detect E-cadherin was for the cytoplasmic domain, and it may be possible that this 
domain remains attached to β-catenin as it moves into the nucleus.  Further study will be 
needed to verify this conclusion. 
AKT Pathway in folate deficient cells 
 We also conducted a western blot analysis for proteins in the AKT pathway.  The 
AKT pathway is an important regulator of cell growth and survival (Itoh et al., 2002).  It 
was surmised that this could be a potential cause for why the cells continued to grow 
even under folate deficient conditions.  We performed a western blot analysis on Caco-2 
cells.  At day 15 there was a decrease in activated AKT protein in folate deficient cells as 
compared to folate sufficient cells.  At day 30 there was an increase in activated AKT 
protein in the folate deficient cells.  This would be the expected result.  However, these 
changes were small and may not be significant. Other proteins involved in the AKT 
pathway were also analyzed to determine if there was increased activity in the AKT 
pathway due to folate deficiency.  At day 30 we found a slight decrease in PDK-1and c-
Raf in folate deficient cells and even less of a decrease in PTEN.  The reduction in PDK-
1 and PTEN could be some form of negative feedback due to increased activation of 
AKT.  PDK-1 phosphorylates AKT which activates the protein so that it can, in turn, 
phosphorylate target proteins such as c-Raf.  PTEN is also a regulator of AKT through 
dephosphorylating lipids involved in the activation of AKT (Paez et al., 2003).  There 
was a slight increase in GSK-3β, which again must be confirmed through biological 
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replicas.  One study has shown that AKT affects β-catenin through disrupting the 
complex that targets it for degradation.  This would help to increase the available β-
catenin that can localize to the nucleus, and increase cell growth and survival (Dihlmann 
et al., 2005).  This mechanism could potentially be proved due to the increase found in 
phospho-GSK3β.  An increase in phosphorylated GSK-3β would help prevent the 
formation of the degradation complex and stabilize the pool of free β-catenin.  This could 
induce Wnt signaling at some level, or prevent the further degradation of β-catenin if 
there was an upregulation of the degradation complex due to increased amounts of β-
catenin being released from the E-cadherin adhesion complex.  If there is indeed some 
Wnt stimulation this could also help to explain the increased membrane recruitment of β-
catenin without increasing E-cadherin. 
Summary 
 In summary, we found that folate deficiency caused slower but continual cell 
proliferation, and that both cell lines continued to cycle.  We also determined that the 
mRNA levels of two folate transporters increased in folate deficient Caco-2 cells. These 
results indicate that the cells are adapting to folate deficiency.  We also found a reduction 
in E-cadherin and β-catenin protein levels, and that there was a change in the localization 
of both proteins due to folate deficiency.  The AKT pathway showed minor changes due 
to folate deficiency, but further study needs to be conducted to see if these changes are 
significant.  We also determined that the transcription levels of two folate uptake 
transporters were affected by folate deficiency.  This leads us to conclude that both cell 
lines may be adapting to folate deficiency.  
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